McClellan Cites OTC Relief For States With Tightened Budget Belts

FDA Commissioner Mark McClellan, MD/PhD, highlighted the cost-effectiveness of OTC drugs in reducing pricing pressures on the healthcare system at an Academy Health/Health Affairs National Health Policy Conference Jan. 28